Lucintel Forecasts The Global Post Herpetic Neuralgia Treatment Market To Grow With A Cagr Of 4% From 2025 To 2031

By Author: Lucintel LLC
Total Articles: 5170
Comment this article

According to a market report by Lucintel, the future of the global post herpetic neuralgia treatment market looks promising with opportunities in the hospital pharmacy, online pharmacy, and retail pharmacy markets. The global post herpetic neuralgia treatment market is expected to grow with a CAGR of 4% from 2025 to 2031. The major drivers for this market are the rising incidence of shingles, the growing awareness of post-herpetic neuralgia, and the increasing availability of advanced treatment options.
A more than 150-page report to understand trends, opportunity and forecast in global post herpetic neuralgia treatment market to 2031 by type (anticonvulsants, skin patch, and other), application (hospital pharmacies, online pharmacies, and retail pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, anticonvulsant is expected to witness higher growth over the forecast period.
Within the application category, retail pharmacy is expected to witness the highest growth.
Download sample by clicking on post herpetic neuralgia ...
... treatment market.
In terms of region, North America is expected to witness the highest growth over the forecast period.
Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, Teva, Mylan are the major suppliers in the post herpetic neuralgia treatment market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Jumbo Reel Market
Intelligent Interactive Home Robot Market
Human Glial Maturation Factor β Reagent Market
Household Flat Microwave Market
High-rise Building Fire Door Market